PQA

DECEMBER 19, 2022

Diversity, equity and inclusion (DEI) have rightfully become a priority for health care organizations across the nation. We have a responsibility to improve DEI because it directly affects patient outcomes and quality of life. Our principles are informed by the many national efforts to improve DEI.

Communication 40

Communication 40

PQA

JUNE 7, 2023

The first bucket is diversity, equity and inclusion (DEI) and the second bucket is health equity. These two topics are linked, but not synonymous. DEI and health equity are often thought of as not being important for business, but competitive advantage happens by prioritizing these areas of social justice.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Medical Schools 52

Pharma Marketing Network

OCTOBER 7, 2022

The gender pay gap is a frequent topic of conversation related to inequities women face in the workplace. It has also won accolades from the Top Employers Institute, which recognized Pfizer, with a DEI score of 100 percent, among its top five positions in the UK in 2022.

52

52

Colors Make me Happy

JANUARY 22, 2021

Corporations have gone above and beyond to publish statements on the big three: Diversity, Equity, and Inclusion (DEI). Many have taken an active role by revisiting their business practices, bylaws, strategic goals, and delivery models to demonstrate their seriousness about DEI. DEI is everyone’s responsibility.

Patient Care 52

Patient Care 52

pharmaphorum

MAY 26, 2022

In recent years this has seen diversity, equity, and inclusion (DEI) become a big focus for industries to get right. The good news is that technology is being harnessed to promote a DEI-conscious agenda within the clinical trial space, making diversity more attainable than it ever has been.

Packaging 143

Packaging Vaccines Generic Medicine Compounding 143

Hospital Pharmacy Europe

JANUARY 18, 2023

Topics included the challenges of managing multimorbidity and frailty, medication errors and appropriate medicines’ use. In his presentation, Professor Martin Henman (Trinity College, Dublin) focused on four key topics – pain, breathlessness, nausea and vomiting, and fatigue. References. Barzilai N et al. Cell Metab 2016;23(6):1060–5.

Scheduling Appointments 98

Scheduling Appointments Chemotherapy Community Pharmacies Patient Care 98

European Pharmaceutical Review

JULY 1, 2022

Diversity and inclusion – pharmaceutical companies may be required to comply with certain legal requirements relating to topics such as inclusion and non-discrimination. Highs and lows of DEI representation in the biotech industry… Changing regulatory expectations. United Kingdom.

Pharmaceutical Companies 92

Pharmaceutical Companies Pharmaceutical Companies Documentation 92